EFFECT OF AMBROXOL ON CYTOKINE LEVELS IN PERIPHERAL BLOOD AND MIDDLE EAR EFFUSION AND PERIPHERAL BLOOD TREGS CELLS IN PATIENTS WITH SECRETORY OTITIS MEDIA

Yiting Wang,Jun Liu,Yi Zhang,Jiping Li
DOI: https://doi.org/10.19193/0393-6384_2019_4_282
2019-01-01
Acta medica mediterranea
Abstract:Objective: To investigate the effects of ambroxol on cytokine levels and peripheral blood Tregs cells in peripheral blood and ear effusions of patients with secretory otitis media. Methods: A total of 106 patients with secretory otitis media admitted to our hospital from July 2017 to June 2018 were randomly divided into a control group (using conventional symptomatic treatment) and a treatment group (adding ambroxol to the control group). The clinical efficacy of the two group was observed. The levels of cytokines in peripheral blood and ear effusions were detected in the two groups, including interleukin-1 beta (IL-1 beta), interleukin-5 (IL- 5), and tumor necrosis factor-alpha (TNF-alpha) and interleukin-8 (IL-8) were used to detect peripheral blood Tregs cell levels in both groups, including CD8(+,) CD4(+) and CD4(+)CD8(+). Results: The total effective rate of the treatment group was 96.23%, which was significantly higher than that of the control group (79.25%) (p<0.05). After treatment, the levels of IL-1 beta, IL-8, IL-5, TNF-alpha and PCT in the peripheral blood and the middle ear effusion of the two groups were significantly lower than those in the group before treatment and the peripheral blood and ear after treatment in the treatment group. The levels of IL-8, IL-1 beta, TNF-alpha and PCT in the effusion were significantly lower than those in the control group (p<0.05). There was no significantly difference in IL-5 between peripheral blood and the middle ear effusion in the two groups after treatment (p>0.05); after treatment, however, the levels of CD4(+) and CD4(+)/CD8(+) in the treatment group were significantly higher than those in the control group (p<0.05). The levels of CD8(+) in the two groups were significantly lower than those in the group before treatment. There was no significant difference in CD8(+) levels between the two groups(p>0.05). Conclusion: Ambroxol has a significant therapeutic effect on secretory otitis media. It can effectively regulate the levels of cytokines in peripheral blood and the middle ear effusion and the level of peripheral blood Tregs cells. It can be widely promoted in clinic.
What problem does this paper attempt to address?